Vaughn Jason 4
4 · AVADEL PHARMACEUTICALS PLC · Filed Nov 14, 2019
Insider Transaction Report
Form 4
Vaughn Jason
Sr. VP, Technical Operations
Transactions
- Award
Stock Option (right to buy)
2019-10-22$3.45/sh+150,000$517,500→ 150,000 totalExercise: $3.45Exp: 2029-10-22→ ADSs (150,000 underlying)
Footnotes (2)
- [F1]Options become exercisable as to 37,500 ADSs on each of the first four anniversaries after the 10/22/2019 grant date.
- [F2]The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.